A detailed history of Addison Advisors LLC transactions in Compugen LTD stock. As of the latest transaction made, Addison Advisors LLC holds 267 shares of CGEN stock, worth $437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267
Previous 267 -0.0%
Holding current value
$437
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$0.88 - $1.31 $1,584 - $2,358
-1,800 Reduced 87.08%
267 $0
Q2 2023

Aug 03, 2023

BUY
$0.57 - $1.38 $1,178 - $2,852
2,067 New
2,067 $2,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.